Activity of human serum antibodies in a hemagglutinin stalk-based ADCC reporter assay correlates with activity in a CD107a degranulation assay
暂无分享,去创建一个
Gonzalez | A. García-Sastre | V. Simon | Veronika Chromikova | F. Krammer | R. Nachbagauer | S. Aslam | Jessica Tan | B. Salaun | González | Arvind Rajabhathor | J. Ayllon | -. MariaBermudez | Juan Ayllon | Raffael Nachbagauer
[1] Christopher T. Stamper,et al. Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial , 2019, The Lancet. Infectious diseases.
[2] M. Colonna,et al. The Natural Cytotoxicity Receptors in Health and Disease , 2019, Front. Immunol..
[3] L. Gresh,et al. Novel correlates of protection against pandemic H1N1 influenza A virus infection , 2019, Nature Medicine.
[4] A. García-Sastre,et al. Chimeric Hemagglutinin-Based Influenza Virus Vaccines Induce Protective Stalk-Specific Humoral Immunity and Cellular Responses in Mice , 2019, ImmunoHorizons.
[5] E. Munari,et al. Human NK cells: surface receptors, inhibitory checkpoints, and translational applications , 2019, Cellular & Molecular Immunology.
[6] A. García-Sastre,et al. Broadly Cross-Reactive, Nonneutralizing Antibodies against Influenza B Virus Hemagglutinin Demonstrate Effector Function-Dependent Protection against Lethal Viral Challenge in Mice , 2019, Journal of Virology.
[7] E. Saphire,et al. Antibody-mediated protection against Ebola virus , 2018, Nature Immunology.
[8] Rafael C Prados-Rosales,et al. Updates on antibody functions in Mycobacterium tuberculosis infection and their relevance for developing a vaccine against tuberculosis. , 2018, Current opinion in immunology.
[9] J. Ravetch,et al. Immunological responses to influenza vaccination: lessons for improving vaccine efficacy. , 2018, Current opinion in immunology.
[10] J. Dye,et al. Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection , 2018, Cell.
[11] Taia T. Wang,et al. The Role of Fc Gamma Receptors in Broad Protection against Influenza Viruses , 2018, Vaccines.
[12] Caitlin E. Mullarkey,et al. Alveolar macrophages are critical for broadly-reactive antibody-mediated protection against influenza A virus in mice , 2017, Nature Communications.
[13] P. Palese,et al. Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for In Vivo Protection in a Serum Transfer Mouse Challenge Model , 2017, mBio.
[14] Veronika Chromikova,et al. Generation of a serum free CHO DG44 cell line stably producing a broadly protective anti-influenza virus monoclonal antibody , 2017, PloS one.
[15] S. Subramaniam,et al. Broadly protective murine monoclonal antibodies against influenza B virus target highly conserved neuraminidase epitopes , 2017, Nature Microbiology.
[16] A. García-Sastre,et al. Novel Cross-Reactive Monoclonal Antibodies against Ebolavirus Glycoproteins Show Protection in a Murine Challenge Model , 2017, Journal of Virology.
[17] R. Hai,et al. Chimeric Hemagglutinin Constructs Induce Broad Protection against Influenza B Virus Challenge in the Mouse Model , 2017, Journal of Virology.
[18] T. Surowy,et al. Characterization of FcγRIIIA effector cells used in in vitro ADCC bioassay: Comparison of primary NK cells with engineered NK-92 and Jurkat T cells. , 2017, Journal of immunological methods.
[19] N. Callewaert,et al. Hierarchical and Redundant Roles of Activating FcγRs in Protection against Influenza Disease by M2e-Specific IgG1 and IgG2a Antibodies , 2017, Journal of Virology.
[20] B. Gunn,et al. Modulating Antibody Functionality in Infectious Disease and Vaccination. , 2016, Trends in molecular medicine.
[21] Caitlin E. Mullarkey,et al. Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus , 2016, Proceedings of the National Academy of Sciences.
[22] Martin H. Koldijk,et al. HA Antibody-Mediated FcγRIIIa Activity Is Both Dependent on FcR Engagement and Interactions between HA and Sialic Acids , 2016, Front. Immunol..
[23] Caitlin E. Mullarkey,et al. Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact , 2016, Proceedings of the National Academy of Sciences.
[24] J. Yewdell,et al. Generation and Protective Ability of Influenza Virus-Specific Antibody-Dependent Cellular Cytotoxicity in Humans Elicited by Vaccination, Natural Infection, and Experimental Challenge. , 2016, The Journal of infectious diseases.
[25] Caitlin E. Mullarkey,et al. Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection. , 2016, Cell host & microbe.
[26] Thomas D. Wu,et al. Two Escape Mechanisms of Influenza A Virus to a Broadly Neutralizing Stalk-Binding Antibody , 2016, PLoS pathogens.
[27] R. Albrecht,et al. Broadly-Reactive Neutralizing and Non-neutralizing Antibodies Directed against the H7 Influenza Virus Hemagglutinin Reveal Divergent Mechanisms of Protection , 2016, PLoS pathogens.
[28] P. Palese,et al. Age Dependence and Isotype Specificity of Influenza Virus Hemagglutinin Stalk-Reactive Antibodies in Humans , 2016, mBio.
[29] R. Hai,et al. Influenza A Viruses Expressing Intra- or Intergroup Chimeric Hemagglutinins , 2016, Journal of Virology.
[30] F. Cox,et al. Protection against H5N1 Influenza Virus Induced by Matrix-M Adjuvanted Seasonal Virosomal Vaccine in Mice Requires Both Antibodies and T Cells , 2015, PloS one.
[31] Quinlin M Hanson,et al. A perspective on the structure and receptor binding properties of immunoglobulin G Fc. , 2015, Biochemistry.
[32] J. Wrammert,et al. Preexisting human antibodies neutralize recently emerged H7N9 influenza strains. , 2015, The Journal of clinical investigation.
[33] F. Ennis,et al. Relationship of preexisting influenza hemagglutination inhibition, complement-dependent lytic, and antibody-dependent cellular cytotoxicity antibodies to the development of clinical illness in a prospective study of A(H1N1)pdm09 Influenza in children. , 2014, Viral immunology.
[34] K. Broman,et al. Modified Vaccinia Virus Ankara Encoding Influenza Virus Hemagglutinin Induces Heterosubtypic Immunity in Macaques , 2014, Journal of Virology.
[35] J. Reichert. Antibody Fc: Linking Adaptive and Innate Immunity , 2014, mAbs.
[36] P. Palese,et al. Broadly neutralizing hemagglutinin stalk–specific antibodies require FcγR interactions for protection against influenza virus in vivo , 2014, Nature Medicine.
[37] T. Friedrich,et al. Antibody-Dependent Cellular Cytotoxicity Is Associated with Control of Pandemic H1N1 Influenza Virus Infection of Macaques , 2013, Journal of Virology.
[38] K. Laurie,et al. Cross-Reactive Influenza-Specific Antibody-Dependent Cellular Cytotoxicity Antibodies in the Absence of Neutralizing Antibodies , 2013, The Journal of Immunology.
[39] N. S. Laursen,et al. Highly Conserved Protective Epitopes on Influenza B Viruses , 2012, Science.
[40] Mark Mulligan,et al. Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells , 2012, Proceedings of the National Academy of Sciences.
[41] Guido Ferrari,et al. Immune-correlates analysis of an HIV-1 vaccine efficacy trial. , 2012, The New England journal of medicine.
[42] R. Nussenblatt,et al. Standardizing immunophenotyping for the Human Immunology Project , 2012, Nature Reviews Immunology.
[43] J. Skehel,et al. A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins , 2011, Science.
[44] M. Bomsel,et al. The broadly neutralizing HIV-1 IgG 2F5 elicits gp41-specific antibody-dependent cell cytotoxicity in a FcγRI-dependent manner , 2011, AIDS.
[45] W. Fiers,et al. Universal Vaccine Based on Ectodomain of Matrix Protein 2 of Influenza A: Fc Receptors and Alveolar Macrophages Mediate Protection , 2011, The Journal of Immunology.
[46] John Steel,et al. Hemagglutinin-Pseudotyped Green Fluorescent Protein-Expressing Influenza Viruses for the Detection of Influenza Virus Neutralizing Antibodies , 2009, Journal of Virology.
[47] R. Center,et al. Rapid Degranulation of NK Cells following Activation by HIV-Specific Antibodies1 , 2009, The Journal of Immunology.
[48] Lewis L Lanier,et al. Up on the tightrope: natural killer cell activation and inhibition , 2008, Nature Immunology.
[49] D. Burton,et al. Fc receptor but not complement binding is important in antibody protection against HIV , 2007, Nature.
[50] M. Glennie,et al. Intimate Cell Conjugate Formation and Exchange of Membrane Lipids Precede Apoptosis Induction in Target Cells during Antibody-Dependent, Granulocyte-Mediated Cytotoxicity1 , 2007, The Journal of Immunology.
[51] D. Venzon,et al. A simplified method for the rapid fluorometric assessment of antibody-dependent cell-mediated cytotoxicity. , 2006, Journal of immunological methods.
[52] D. Metzger,et al. Fc Receptor-Mediated Phagocytosis Makes a Significant Contribution to Clearance of Influenza Virus Infections1 , 2001, The Journal of Immunology.
[53] D. Davies,et al. Development of a novel flow cytometric cell-mediated cytotoxicity assay using the fluorophores PKH-26 and TO-PRO-3 iodide. , 2001, Journal of immunological methods.
[54] K. Nagashima,et al. Direct evidence for release of pore‐forming protein during NK cellular lysis , 1992, Journal of leukocyte biology.
[55] T. Masuko,et al. Release of Esterase from Murine Lymphokine‐activated Killer Cells in Antibody‐dependent Cellular Cytotoxic Reaction , 1991, Japanese journal of cancer research : Gann.
[56] E. Saksela,et al. A simplified isotope release assay for cell-mediated cytotoxicity against anchorage dependent target cells. , 1977, Journal of immunological methods.
[57] M. Koopmans,et al. Primary Human Influenza B Virus Infection Induces Cross-Lineage Hemagglutinin Stalk–Specific Antibodies Mediating Antibody-Dependent Cellular Cytoxicity , 2017, The Journal of infectious diseases.
[58] L. Goetsch,et al. Evaluation of antibody-dependent cell cytotoxicity using lactate dehydrogenase (LDH) measurement. , 2013, Methods in molecular biology.
[59] C. Pipho,et al. Use of propidium iodide staining and flow cytometry to measure anti-mediated cytotoxicity: resolution of complement-sensitive and resistant target cells. , 1983, Journal of immunological methods.